RED HERRING: Not an offer to invest. Professional Investors, Qualified Institutional Buyers, Accredited Investors, by Invitation only.

Vaccines & Immunity

As of April 8, 2020, CEPI reports 115 vaccine candidates are in varying stages of development, 78 of which are confirmed as active and 37 are unconfirmed. To end the COVID-19 Pandemic safe and effective vaccines will be required for the entire global population. Estimated requirement: 5 billion doses.
Published for educational purposes and social benefit, not for profit. Not a recommendation or endorsement. Always consult your doctor for medical advice.

October 2020

September 2020

COVAX: CEPI’s response to COVID-19

2020-09-19T14:00:20+00:00September 19th, 2020|

CEPI, Gavi and the WHO have launched COVAX to ensure equitable access to COVID-19 vaccines and end the acute phase of the pandemic by the end of 2021. The Scale [...]

JAMA | COVID-19 and the Path to Immunity

2020-10-11T12:08:48+00:00September 11th, 2020|

Reprinted for educational purposes and social benefit, not for profit.  The emergence of adaptive immunity in response to the novel Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurs within [...]